How Vene will measure care follow-through

The primary measure is the share of eligible administrative care tasks that reach a verified terminal state within the prespecified window. A task must be defined before enrollment and tied to a source that can confirm its state.

• Completed: the intended organization confirms the action, such as an appointment booked or a refill ready.
• Informed decline: the patient or authorized person understands the option and declines it.
• Clinician decision: a clinician reviews the request and changes, pauses, or ends the plan.
• Blocked: the task cannot proceed because a named dependency remains, such as missing authorization or unavailable records.
• Unverified: Vene has an attempt or report but lacks a source that can confirm the final state.

A future result must state the organization and care setting, eligibility and exclusion rules, enrollment dates, number invited, number enrolled, number with usable follow-up, and the full observation period. Vene will not combine unlike workflows into one success rate or choose a more favorable window after reviewing results.

• Define one primary workflow and its terminal states before the first participant begins.
• Use time-stamped product events plus confirmation from the patient, caregiver, provider office, pharmacy, health plan, or source record.
• Report the numerator, denominator, missing-data count, and exclusions alongside every rate.
• Separate Vene-completed work from work completed by the patient, family, staff, or another organization.
• Keep safety escalations and clinical decisions separate from administrative completion.
• Have a named reviewer check the method, source table, calculations, and limitations before publication.

A study may also report time to first contact, contact completion, time to verified state, staff handoffs, patient or family-reported burden, and the share of work that remains blocked. Clinical measures require a suitable design, qualified review, and a clear basis for attributing any change. They will not be presented as product effects merely because they changed during a pilot.

• This is a prospective measurement method, not a study result.
• There is no completed cohort, comparison group, effect estimate, or statistical analysis.
• The method may change before enrollment; any material change will receive a new update date and explanation.
• A future design-partner cohort may be small and may not represent other patients, organizations, or care settings.
• Administrative task completion does not by itself prove a clinical benefit.